FluoGuide is a clinical-stage biotech company specializing in precision cancer surgery. Our mission is to improve outcomes for cancer patients by helping surgeons remove cancer more accurately. Our lead product, FG001, has been clinically proven to light up cancer during surgery, guiding more precise removal while preserving healthy tissue. FG001 has shown strong results in brain, head and neck, and lung cancers, and is well-tolerated by patients. Scientific data and clinical experience suggest its broad potential across solid tumor types. Strategic partnerships with surgical equipment manufacturers support integration and wide adoption of FG001 in the operating room.
FluoGuide is listed on the Nasdaq First North Growth Market in Stockholm under the ticker symbol "FLUO." For more information about FluoGuide's pipeline, technology, and upcoming events, visit www.fluoguide.com.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Titangade 9-13, Copenhagen,capital Region Of Denmark 2200,denmark
- Phone
- +45 31 31 43 73|
- in****@****ide.com
- Industry
- Biotechnology
- Website
- fluoguide.com
- Keywords
- Ceremedy Aps.
- HQ
- Copenhagen, Capital Region of Denmark
Fluoguide A/s (Nasdaq: Fluo) Questions
Fluoguide A/S (Nasdaq: Fluo)'s helpline number is +45 31 31 43 73|
Fluoguide A/S (Nasdaq: Fluo)'s website is fluoguide.com
Fluoguide A/S (Nasdaq: Fluo)'s LinkedIn profile is https://dk.linkedin.com/company/fluoguide
Fluoguide A/S (Nasdaq: Fluo) has
12 employees.
View email and phone details for 12
employees at Fluoguide A/S (Nasdaq: Fluo).
Fluoguide A/S (Nasdaq: Fluo)'s industry is
Biotechnology
Fluoguide A/S (Nasdaq: Fluo)'s top competitors are
Novo Nordisk,
Lundbeck,
Triptobio,
Muna Therapeutics,
Curasight,
Zealand Pharma,
Cessatech A/s,
Cluster For Molecular Imaging,
Minerva Imaging,
Ceremedy Aps.
Fluoguide A/S (Nasdaq: Fluo)'s support email address is info@fluoguide.com
Fluoguide A/S (Nasdaq: Fluo)'s categories are Biotechnology
Fluoguide A/S (Nasdaq: Fluo)'s founding year is 2018
